[an error occurred while processing this directive]
Reviews

Application of next generation sequencing in gene identification and genetic diagnosis of hereditary hearing loss

Expand
  • Institute of Otolaryngology, Chinese PLA General Hospital, Beijing 100853, China

Received date: 2014-07-01

  Online published: 2014-10-28

Abstract

More than 50% cases with hearing loss are caused by genetic defects. With the development of genomics technology, molecular genetics of hearing loss has become a cutting-edge field under investigation in otology. The next generation sequencing has provided a new model originated from sequencing data to genetic disease study, and has made a revolutionary change in the strategy of gene identification for genetic diseases. Due to the application of next generation sequencing technology, gene identification of hearing loss has been accelerated in recent years, and moreover, the new technology and strategy were explored to clinical application. In this review, we briefly introduce the current situation of hereditary hearing loss research, and the application and perspective of next generation sequencing in this field.

Cite this article

Huijun Yuan, Yu Lu . Application of next generation sequencing in gene identification and genetic diagnosis of hereditary hearing loss[J]. Hereditas(Beijing), 2014 , 36(11) : 1112 -1120 . DOI: 10.3724/SP.J.1005.2014.1112

References

[1] 于丽玫, 曲成毅, 梁巍, 王琦, 魏志云. 中国听力残疾构成特点及康复对策. 中国听力语言康复科学杂志, 2008, (2): 21–24.
[2] 中国出生缺陷防治报告. 2012.
[3] MS, DeLuca AP, Taylor KR, Hoskinson DP, Hur IA, Tack D, McMordie SJ, Huygen PLM, Casavant TL, Smith RJH. A contemporary review of AudioGene audioprofiling: a machine-based candidate gene prediction tool for autosomal dominant nonsyndromic hearing loss. Laryngoscope , 2009, 119(11): 2211–2215.
[4] D, Risch N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet , 2003, 33(Suppl): 228–237.
[5] N, Smith RJH, Van Camp G. Forty-six genes cau-sing nonsyndromic hearing impairment: which ones should be analyzed in DNA diagnostics? Mutat Res , 2009, 681(2–3): 189–196.
[6] NH, Prucka SK, Woolley AL, Smith RJH. The use of genetic testing in the evaluation of hearing impairment in a child. Curr Opin Pediatr , 2005, 17(6): 709–712.
[7]
[8]
[9]
[10] P, Oitmaa E, Messner A, Hoefsloot L, Metspalu A, Schrijver I. Simultaneous multigene mutation detection in patients with sensorineural hearing loss through a novel diagnostic microarray: a new approach for newborn screening follow-up. Pediatrics , 2006, 118(3): 985–994.
[11] J, Pique L, Colen T, Roberson J, Gardner P, Schrijver I. Genotyping with a 198 mutation arrayed primer extension array for hereditary hearing loss: assess-ment of its diagnostic value for medical practice. PLoS ONE , 2010, 5(7): e11804.
[12] K, Manji SSM, Hutchison WM, Du Sart D, Phelan D, Dahl HHM. Detection of mutations in genes associated with hearing loss using a microarray-based approach. J Mol Diagn , 2006, 8(4): 483–489; quiz 528.
[13] P, Cox S, Ebert J, Husami A, Kenna MA, Greinwald JH, Aronow BJ, Rehm HL. High-throughput detection of mutations responsible for childhood hearing loss using resequencing microarrays. BMC Biotechnol , 2010, 10: 10.
[14]
[15] S, Yamaguchi T, Usami SI. Application of deafness diagnostic screening panel based on deafness mutation/gene database using invader assay. Genet Test , 2007, 11(3): 333–340.
[16] BG, Clark RH, Kelleher AS, Lin ZL, Spitzer AR, Pediatrix SoundGene® Study Group Principal Investigators and Contributors. Utility of genetic testing for the detection of late-onset hearing loss in neonates. Am J Audiol , 2013, 22(2): 209–215.
[17]
[18] A, Melnikov A, Maguire J, Rogov P, LeProust EM, Brockman W, Fennell T, Giannoukos G, Fisher S, Russ C, Gabriel S, Jaffe DB, Lander ES, Nusbaum C. Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nat Biotechnol , 2009, 27(2): 182–189.
[19] A, Quackenbush J, Thompson JF. What would you do if you could sequence everything? Nat Biotechnol , 2008, 26: 1125–1133.
[20] MJ, Chen R, Lam HYK, Karczewski KJ, Chen R, Euskirchen G, Butte AJ, Snyder M. Performance comparison of exome DNA sequencing technologies. Nat Biotechnol , 2011, 29: 908–914.
[21] AU, Morell RJ, Belyantseva IA, Khan SY, Boger ET, Shahzad M, Ahmed ZM, Riazuddin S, Khan SN, Riazuddin S, Friedman TB. Targeted capture and next- generation sequencing identifies C9orf75, encoding taperin, as the mutated gene in nonsyndromic deafness DFNB79. Am J Hum Genet , 2010, 86(3): 378–388.
[22] A, Walsh T, Akay H, Spiliopoulos M, Sakalar YB, Hasanefendioğlu-Bayrak A, Duman D, Farooq A, King MC, Tekin M. MASP1 mutations in patients with facial, umbilical, coccygeal, and auditory findings of Carnevale, Malpuech, OSA, and Michels syndromes. Am J Hum Genet , 2010, 87(5): 679–686.
[23] AK, Gandia M, Frommolt P, Maak A, Wicklein EM, Thiele H, Altmuller J, Wagner F, Viñuela A, Aguirre LA, Moreno F, Maier H, Rau I, Gießelmann S, Nürnberg G, Gal A, Nürnberg P, Hübner CA, del Castillo I, Kurth I. Nonsense mutati
Outlines

/